StereoDive will take part in an upcoming Capital Cell webinar on 17 June 2026 at 6:30 pm CEST, focused on how professional investors evaluate medical software companies.
The session, titled “Why Medical Software Can Be a Strong Investment Opportunity: What Inveready Saw in StereoDive”, will bring together Antonio Herce, Investment Director at Inveready, and Antoni Riu, CEO & co-founder of StereoDive.
How do professional investors evaluate medical software companies?
In this Capital Cell webinar, Antonio Herce from Inveready and Antoni Riu from StereoDive will discuss why medical software can be a strong investment opportunity, what investors look for before committing capital, and how StereoDive fits this investment thesis.
Who should attend?
This webinar is designed for private investors, business angels, healthcare and MedTech investors, Capital Cell followers, and professionals interested in understanding how specialised clinical software can become a strategic layer within advanced medical procedures.